Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Ozempic is sold in injection pens containing 0.25 and ... is sold by Sanofi under the brand name Soliqua. Soliqua contains a combination of lixisenatide and insulin. It is registered for the treatment ...

Insulin, a hormone produced by the pancreas, plays a major role in blood sugar regulation. One of its primary jobs is taking up sugar from the bloodstream into the cells so the body can use it for ...

If you are drinking fruit juice on occasion, going for 100 per cent options may be your best bet. An article entitled 'Intake of Fruit Juice and Incidence of Type 2 Diabetes: A Systematic Review and ...